These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 30499740)
21. Therapeutic approaches of magnetic nanoparticles for the central nervous system. Dilnawaz F; Sahoo SK Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617 [TBL] [Abstract][Full Text] [Related]
22. Drug delivery to brain via the blood-brain barrier. Scherrmann JM Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929 [TBL] [Abstract][Full Text] [Related]
23. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery. Vlieghe P; Khrestchatisky M Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495 [TBL] [Abstract][Full Text] [Related]
24. Nanotechnology in Neuroscience and its Perspective as Gene Carrier. Khanh TMT; Wei D; Tran PHL; Tran TTD Curr Top Med Chem; 2017; 17(12):1379-1389. PubMed ID: 28017150 [TBL] [Abstract][Full Text] [Related]
25. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System. Shahjin F; Chand S; Yelamanchili SV J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884 [TBL] [Abstract][Full Text] [Related]
26. Customizing delivery nano-vehicles for precise brain tumor therapy. Miao YB; Zhao W; Renchi G; Gong Y; Shi Y J Nanobiotechnology; 2023 Jan; 21(1):32. PubMed ID: 36707835 [TBL] [Abstract][Full Text] [Related]
27. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms. Song J; Lu C; Leszek J; Zhang J Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576281 [TBL] [Abstract][Full Text] [Related]
28. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948 [TBL] [Abstract][Full Text] [Related]
29. [Research advances in brain-targeted nanoscale drug delivery system]. Liu Y; Jiang C Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079 [TBL] [Abstract][Full Text] [Related]
30. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders. Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274 [TBL] [Abstract][Full Text] [Related]
31. Strategies for drug delivery to the central nervous system by systemic route. Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801 [TBL] [Abstract][Full Text] [Related]
32. Getting into the brain: approaches to enhance brain drug delivery. Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the RBE4 cell line to explore carrier-mediated drug delivery to the CNS via the L-system amino acid transporter at the blood-brain barrier. Reichel A; Abbott NJ; Begley DJ J Drug Target; 2002 Jun; 10(4):277-83. PubMed ID: 12164376 [TBL] [Abstract][Full Text] [Related]
34. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases. Ceña V; Játiva P Nanomedicine (Lond); 2018 Jul; 13(13):1513-1516. PubMed ID: 29998779 [No Abstract] [Full Text] [Related]
35. Crossing the blood-brain barrier with nanoparticles. Zhou Y; Peng Z; Seven ES; Leblanc RM J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142 [TBL] [Abstract][Full Text] [Related]
36. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain. Patel MM; Patel BM CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766 [TBL] [Abstract][Full Text] [Related]
37. A New Noncanonical Anionic Peptide That Translocates a Cellular Blood-Brain Barrier Model. Neves-Coelho S; Eleutério RP; Enguita FJ; Neves V; Castanho MARB Molecules; 2017 Oct; 22(10):. PubMed ID: 29057814 [TBL] [Abstract][Full Text] [Related]
38. Nanotechnological advances for the delivery of CNS therapeutics. Wong HL; Wu XY; Bendayan R Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125 [TBL] [Abstract][Full Text] [Related]
39. Noninvasive nanoparticle strategies for brain tumor targeting. Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093 [TBL] [Abstract][Full Text] [Related]
40. Vector-mediated drug delivery to the brain. Temsamani J; Rousselle C; Rees AR; Scherrmann JM Expert Opin Biol Ther; 2001 Sep; 1(5):773-82. PubMed ID: 11728213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]